苏州贝康医疗股份有限公司（股票代码：2170）于2026年1月6日发布截至2025年12月31日的月度股份变动报告。公告显示，本月公司已发行H股、内资股及未上市外资股数量均无新增或减少，相关股本结构维持稳定。
根据公告，截至2025年12月31日，公司注册股本合计为人民币273,526,000元，其中H股82,713,835股、内资股183,181,817股、未上市外资股7,630,348股，所有股份面值均为人民币1元。与上月相比，各类股份数量及已发行总股本并未发生变化。
报告还披露，公司在期内无开展购回及注销活动，亦未发生库存股变动及股份期权或股权激励的授出、行使与失效情况。截至报告期末，公司及其附属公司并未回购任何上市证券。
公司强调，已遵守香港联交所的相关上市规则及法律要求。公告由执行董事梁波签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.